• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾塞那肽致注射部位嗜酸性硬化性脂肪肉芽肿

Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site.

作者信息

Shan Shi-Jun, Guo Ying

机构信息

*Ackerman Academy of Dermatopathology, New York, NY; and †Department of Dermatology, Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.

出版信息

Am J Dermatopathol. 2014 Jun;36(6):510-2. doi: 10.1097/DAD.0000000000000036.

DOI:10.1097/DAD.0000000000000036
PMID:24366197
Abstract

Sclerosing lipogranuloma is a granulomatous reaction to the injection of a high-viscosity fluid in the tissues for the cosmetic purpose of improving body contour; lesions on the extremities and buttocks are commonly the results of injections of therapeutic agents in oily vehicles. Exenatide, once-weekly injection, is a therapeutic method for patients with type 2 diabetes. Here, we describe a case of exenatide once weekly induced eosinophilic sclerosing lipogranuloma at the injection site of a 62-year-old patient. To the best of our knowledge, the histopathologic features of this adverse event have not been reported in the medical literature.

摘要

硬化性脂肪肉芽肿是机体为改善身体轮廓进行美容目的而在组织中注射高粘性液体所引发的一种肉芽肿反应;四肢和臀部的病变通常是油性载体中注射治疗药物所致。艾塞那肽每周一次注射是2型糖尿病患者的一种治疗方法。在此,我们描述了一例62岁患者在艾塞那肽每周一次注射部位发生嗜酸性硬化性脂肪肉芽肿的病例。据我们所知,该不良事件的组织病理学特征在医学文献中尚未见报道。

相似文献

1
Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site.艾塞那肽致注射部位嗜酸性硬化性脂肪肉芽肿
Am J Dermatopathol. 2014 Jun;36(6):510-2. doi: 10.1097/DAD.0000000000000036.
2
Exenatide-Induced Eosinophil-Rich Granulomatous Panniculitis: A Novel Case Showing Injected Microspheres.艾塞那肽诱导的富含嗜酸性粒细胞的肉芽肿性脂膜炎:一例显示注射微球的新病例。
Am J Dermatopathol. 2015 Oct;37(10):801-2. doi: 10.1097/DAD.0000000000000243.
3
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.艾塞那肽注射引起的富含嗜酸性粒细胞的肉芽肿性脂膜炎。
J Cutan Pathol. 2014 Jan;41(1):63-5. doi: 10.1111/cup.12246. Epub 2013 Nov 14.
4
Once-weekly exenatide: an extended-duration glucagon-like peptide agonist for the treatment of type 2 diabetes mellitus.每周一次 exenatide:一种延长作用时间的胰高血糖素样肽激动剂,用于治疗 2 型糖尿病。
Pharmacotherapy. 2013 Jun;33(6):627-38. doi: 10.1002/phar.1240. Epub 2013 Apr 1.
5
Exenatide for once-weekly administration.用于每周一次给药的艾塞那肽。
Drug Ther Bull. 2012 Jul;50(7):78-80. doi: 10.1136/dtb.2012.06.0115.
6
Review of the safety and efficacy of exenatide once weekly for the treatment of type 2 diabetes mellitus.度拉糖肽每周一次治疗2型糖尿病的安全性和有效性综述。
Ann Pharmacother. 2012 Jun;46(6):812-21. doi: 10.1345/aph.1Q722. Epub 2012 Jun 5.
7
Exenatide added to insulin. Beware the potentially serious adverse effects of exenatide.
Prescrire Int. 2013 Jun;22(139):151.
8
Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.艾塞那肽:注射时间对2型糖尿病患者餐后血糖的影响
Diabet Med. 2006 Mar;23(3):240-5. doi: 10.1111/j.1464-5491.2006.01800.x.
9
Exenatide (Byetta) for type 2 diabetes.艾塞那肽(百泌达)用于2型糖尿病。
Med Lett Drugs Ther. 2005 Jun 6;47(1210):45-6.
10
Carbol fuchsin stain enhances detection of poly-(d, l-lactide-co-glycolide) microspheres in exenatide extended-release cutaneous injection-site foreign body reaction.结晶紫-复红染色增强了对 exenatide 延长释放皮内注射部位异物反应中聚(D,L-丙交酯-共-乙交酯)微球的检测。
J Cutan Pathol. 2021 Dec;48(12):1520-1522. doi: 10.1111/cup.14110. Epub 2021 Aug 12.

引用本文的文献

1
A Closer Look at the Dermatological Profile of GLP-1 Agonists.深入探究胰高血糖素样肽-1受体激动剂的皮肤学特征
Diseases. 2025 Apr 22;13(5):127. doi: 10.3390/diseases13050127.
2
A Review of Glucagon-like Peptide-1 in Dermatology.胰高血糖素样肽-1在皮肤病学中的综述。
J Clin Aesthet Dermatol. 2025 Mar;18(3):42-50.
3
The potential adverse effects of hypodermic glucagon-like peptide -1 receptor agonist on patients with type 2 diabetes: A population-based study.基于人群的研究:皮下注射胰高血糖素样肽-1 受体激动剂对 2 型糖尿病患者的潜在不良影响。
J Diabetes. 2024 Oct;16(10):e70013. doi: 10.1111/1753-0407.70013.
4
Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature.与 GLP-1 激动剂相关的罕见皮肤不良反应:文献复习。
Arch Dermatol Res. 2024 May 25;316(6):248. doi: 10.1007/s00403-024-02969-3.
5
Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature.胰高血糖素样肽-1 受体激动剂(GLP-1 RA)治疗相关嗜酸性粒细胞疾病:病例报告及文献复习。
Clin Rheumatol. 2023 Sep;42(9):2501-2506. doi: 10.1007/s10067-023-06612-w. Epub 2023 May 18.
6
Eosinophilic Panniculitis Following the Subcutaneous Injection of Exenatide Extended-Release.皮下注射艾塞那肽缓释剂后发生的嗜酸性脂膜炎
Ann Dermatol. 2020 Jun;32(3):230-232. doi: 10.5021/ad.2020.32.3.230. Epub 2020 Apr 24.
7
Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS.使用超高效液相色谱-串联质谱法对治疗性肽艾塞那肽进行超灵敏生物分析,以在有效血浆浓度下进行准确的药代动力学分析。
J Pharm Anal. 2020 Jun;10(3):233-239. doi: 10.1016/j.jpha.2020.02.008. Epub 2020 Feb 22.
8
HYPOTHYROIDISM COULD BE A POTENTIAL FACTOR TO PROLONG SUBCUTANEOUS NODULES OF EXENATIDE ONCE WEEKLY: A CASE REPORT.甲状腺功能减退可能是导致艾塞那肽皮下结节每周一次给药后持续存在的一个潜在因素:病例报告。
AACE Clin Case Rep. 2019 Apr 25;5(3):e197-e200. doi: 10.4158/ACCR-2018-0418. eCollection 2019 May-Jun.
9
Persistent injection site nodules from exenatide: Successful treatment with intralesional triamcinolone.艾塞那肽导致的持续性注射部位结节:病灶内注射曲安奈德治疗成功
JAAD Case Rep. 2018 Sep 18;4(8):830-832. doi: 10.1016/j.jdcr.2018.06.009. eCollection 2018 Sep.
10
Late-Onset Complication of Fillers: Paraffinoma of the Lower Eyelids Clinically Mimicking Xanthelasma.填充剂的迟发性并发症:下眼睑石蜡瘤,临床症状类似睑黄瘤。
Ann Dermatol. 2016 Dec;28(6):753-756. doi: 10.5021/ad.2016.28.6.753. Epub 2016 Nov 23.